BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warmbrunn MV, Herrema H, Aron-Wisnewsky J, Soeters MR, Van Raalte DH, Nieuwdorp M. Gut microbiota: a promising target against cardiometabolic diseases. Expert Rev Endocrinol Metab 2020;15:13-27. [PMID: 32066294 DOI: 10.1080/17446651.2020.1720511] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Zheng S, Jiang S, Chen J, Zhu X, Zhang Y. The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis. Front Endocrinol 2022;13:927959. [DOI: 10.3389/fendo.2022.927959] [Reference Citation Analysis]
2 Sumida K, Han Z, Chiu C, Mims TS, Bajwa A, Demmer RT, Datta S, Kovesdy CP, Pierre JF. Circulating Microbiota in Cardiometabolic Disease. Front Cell Infect Microbiol 2022;12:892232. [DOI: 10.3389/fcimb.2022.892232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao M, Pi Y, Zhang L, Che H. Knowledge Discovery-Based Analysis of Health Factors of Urinary Infections in Elderly Cardiology Inpatients. Journal of Healthcare Engineering 2022;2022:1-8. [DOI: 10.1155/2022/7037037] [Reference Citation Analysis]
4 Amiri P, Hosseini SA, Ghaffari S, Tutunchi H, Ghaffari S, Mosharkesh E, Asghari S, Roshanravan N. Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review. Front Pharmacol 2021;12:837509. [PMID: 35185553 DOI: 10.3389/fphar.2021.837509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Callender C, Attaye I, Nieuwdorp M. The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases. Metabolites 2022;12:65. [PMID: 35050187 DOI: 10.3390/metabo12010065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Attaye I, van Oppenraaij S, Warmbrunn MV, Nieuwdorp M. The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets. Nutrients 2021;14:191. [PMID: 35011071 DOI: 10.3390/nu14010191] [Reference Citation Analysis]
7 Wang Q, Wang Y, Wang YJ, Ma N, Zhou YJ, Zhuang H, Zhang XH, Li C, Pei YH, Liu SL. Dissection of the Functional Mechanism of Human Gut Bacterial Strain AD16 by Secondary Metabolites' Identification, Network Pharmacology, and Experimental Validation. Front Pharmacol 2021;12:706220. [PMID: 34803669 DOI: 10.3389/fphar.2021.706220] [Reference Citation Analysis]
8 Koopen A, Witjes J, Wortelboer K, Majait S, Prodan A, Levin E, Herrema H, Winkelmeijer M, Aalvink S, Bergman JJGHM, Havik S, Hartmann B, Levels H, Bergh PO, van Son J, Balvers M, Bastos DM, Stroes E, Groen AK, Henricsson M, Kemper EM, Holst J, Strauch CM, Hazen SL, Bäckhed F, De Vos WM, Nieuwdorp M, Rampanelli E. Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study. Gut 2021:gutjnl-2020-323297. [PMID: 34697034 DOI: 10.1136/gutjnl-2020-323297] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zwartjes MSZ, Gerdes VEA, Nieuwdorp M. The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions. Metabolites 2021;11:531. [PMID: 34436472 DOI: 10.3390/metabo11080531] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Witkowski M, Witkowski M, Friebel J, Buffa JA, Li XS, Wang Z, Sangwan N, Li L, DiDonato JA, Tizian C, Haghikia A, Kirchhofer D, Mach F, Räber L, Matter CM, Tang WHW, Landmesser U, Lüscher TF, Rauch U, Hazen SL. Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. Cardiovasc Res 2021:cvab263. [PMID: 34352109 DOI: 10.1093/cvr/cvab263] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
11 Dubinski P, Czarzasta K, Cudnoch-Jedrzejewska A. The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress. Curr Hypertens Rep 2021;23:31. [PMID: 34014393 DOI: 10.1007/s11906-021-01144-7] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Warmbrunn MV, Koopen AM, de Clercq NC, de Groot PF, Kootte RS, Bouter KEC, Ter Horst KW, Hartstra AV, Serlie MJ, Ackermans MT, Soeters MR, van Raalte DH, Davids M, Nieuwdorp M, Groen AK. Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk. Metabolites 2021;11:236. [PMID: 33924347 DOI: 10.3390/metabo11040236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Swanepoel I, Roberts A, Brauns C, Chaliha DR, Papa V, Palmer RD, Vaccarezza M. Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk. Postgrad Med J 2021:postgradmedj-2021-139839. [PMID: 33790031 DOI: 10.1136/postgradmedj-2021-139839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhao Y, Li M, Tian X, Xie J, Liu P, Ying X, Wang M, Yuan J, Gao Y, Tian F, Yan X. Effects of arsenic exposure on lipid metabolism: a systematic review and meta-analysis. Toxicol Mech Methods 2021;31:188-96. [PMID: 33472496 DOI: 10.1080/15376516.2020.1864537] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
15 Balvers M, van den Born BH, Levin E, Nieuwdorp M. Impact drugs targeting cardiometabolic risk on the gut microbiota. Curr Opin Lipidol 2021;32:38-54. [PMID: 33332920 DOI: 10.1097/MOL.0000000000000727] [Reference Citation Analysis]
16 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies. Gastroenterology 2021;160:573-99. [PMID: 33253685 DOI: 10.1053/j.gastro.2020.10.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
17 Ortega MA, Fraile-Martínez O, Naya I, García-Honduvilla N, Álvarez-Mon M, Buján J, Asúnsolo Á, de la Torre B. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients 2020;12:E2749. [PMID: 32917030 DOI: 10.3390/nu12092749] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
18 Conteh AR, Huang R. Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes. Toxicol Res (Camb) 2020;9:569-77. [PMID: 32905261 DOI: 10.1093/toxres/tfaa065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Simó C, García-Cañas V. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food Funct 2020;11:6745-76. [PMID: 32686802 DOI: 10.1039/d0fo01237h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
20 Papandreou C, Moré M, Bellamine A. Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect? Nutrients 2020;12:E1330. [PMID: 32392758 DOI: 10.3390/nu12051330] [Cited by in Crossref: 28] [Cited by in F6Publishing: 42] [Article Influence: 14.0] [Reference Citation Analysis]